Frontida Biopharm
Exton
About Frontida Biopharm
Frontida Biopharm, Inc., an affiliate of Frontage Laboratories, Inc., is a Contract Development and Manufacturing Organization supporting biopharmaceutical companies in the scale-up and commercial manufacture of immediate and controlled release oral solid dose products. Frontida offers the capability to manufacture Highly Potent Active Ingredient (HPAI) products, Combination Products, as well as DEA schedules II – V products. Its patented Duragran® granulation process eliminates the need for traditional extrusion and compaction manufacturing steps, enhances drug loading, and creates better engineered and lower production-cost controlled release products.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $50K – $100K
- Total funding: $8.3M
- Funding stage: M&A
- Last round: Series Unknown (Aug 2016)
- Website: frontidabiopharm.com
- Phone: (484)348-4802
Industries & Categories
Affiliate Marketing, Biopharma, Biotechnology, Health Care, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/frontida-biopharm-26631 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.